Subtitle
Proton beam therapy achieves excellent local control for recurrent epithelial ovarian cancer: a single-center retrospective study.
Subtitle
Proton beam therapy achieves excellent local control for recurrent epithelial ovarian cancer: a single-center retrospective study.
Proto therapy Time
May 2025
Executive summary
This study reported clinical outcomes of 13 patients with recurrent epithelial ovarian cancer treated with proton therapy. The 1- and 2-year local control were 91.5% and 71.3%, respectively. The median PFS and OS were 9.6 and 21.5 months, respectively. No grade 3 or higher radiaiton-induced adverse events were observed. The authors suggested that proton therapy may be a promising treatment option.
Top cancer treatments
Related contents
Proton Therapy Publication
March 2025
Long Term Results of a Phase II Study of Adjuvant Proton Radiotherapy for Node-Positive Cancer of the Uterus and Cervix: Proton Radiation for Uterine/Cervical Cancer.
Proton Therapy Publication
May 2024
Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies.
Proton Therapy Publication
May 2023
Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.
Proton Therapy Publication
November 2022
Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer.
Proton Therapy Publication
January 2023
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
Proton Therapy Publication
July and August 2023
Treatment Tolerability and Toxicity of Postoperative Proton Beam Therapy for Gynecologic Malignancies: Results of the Prospective Phase 2 APROVE Trial.
Proton Therapy Publication
May 2023
Acute and long-term toxicity of whole pelvis proton radiation therapy for definitive or adjuvant management of gynecologic cancers.